Enhanced tumor immune surveillance through neutrophil reprogramming due to Tollip deficiency
- 24 January 2019
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 4 (2)
Abstract
Although the importance of the tumor immune environment for the modulation of tumorigenesis and tumor regression is becoming increasingly clear, most of the research related to tumor-immune therapies has focused on adaptive immune cells, while the role and regulation of innate leukocytes such as neutrophils remains controversial and less defined. Here we observed that the selective deletion of Tollip, a key innate immune-cell modulator, led to enhanced tumor immune surveillance in a chemically induced colorectal cancer model. Tollip-deficient neutrophils significantly elevated T cell activation through enhanced expression of the costimulatory molecule CD80, and reduced expression of the inhibitory molecule PD-L1. Mechanistically, Tollip deficiency increased STAT5 and reduced STAT1, the transcription factors responsible for the expression of CD80 and PD-L1, respectively. Through adoptive transfer, we demonstrate that Tollip-deficient neutrophils, but not Tollip-deficient monocytes, are sufficient to drive enhanced tumor immune surveillance and reduced colorectal cancer burden in vivo. Our data reveal a strategy for the reprogramming of neutrophil functions conducive for the enhancement of the antitumor immune environment.Keywords
Funding Information
- National Institutes of Health (AI,136386)
This publication has 34 references indexed in Scilit:
- Combination cancer immunotherapies tailored to the tumour microenvironmentNature Reviews Clinical Oncology, 2015
- Super-low Dose Endotoxin Pre-conditioning Exacerbates Sepsis MortalityEBioMedicine, 2015
- Autophagic Clearance of PolyQ Proteins Mediated by Ubiquitin-Atg8 Adaptors of the Conserved CUET Protein FamilyCell, 2014
- The Multifaceted Roles Neutrophils Play in the Tumor MicroenvironmentCancer Microenvironment, 2014
- IDO1 Metabolites Activate β-catenin Signaling to Promote Cancer Cell Proliferation and Colon Tumorigenesis in MiceGastroenterology, 2013
- GPR15-Mediated Homing Controls Immune Homeostasis in the Large Intestine MucosaScience, 2013
- Molecular Mechanisms Responsible for the Selective and Low-Grade Induction of Proinflammatory Mediators in Murine Macrophages by LipopolysaccharideThe Journal of Immunology, 2012
- The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studiesJournal of Carcinogenesis, 2011
- Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4Proceedings of the National Academy of Sciences, 2010
- The paradox of tumor-associated neutrophils: Fueling tumor growth with cytotoxic substancesCell Cycle, 2010